Bank Of New York Mellon Corp Maxcyte, Inc. Transaction History

Bank Of New York Mellon Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.92 - $7.4 $1.66 Million - $2.5 Million	338,282 New	338,282 $1.85 Million
Q3 2022 Nov 14, 2022	BUY	$4.52 - $6.51 $287,883 - $414,628	63,691 Added 23.58%	333,773 $2.17 Million
Q2 2022 Aug 15, 2022	SELL	$3.59 - $6.81 $111,616 - $211,729	-31,091 Reduced 10.32%	270,082 $1.28 Million
Q1 2022 May 11, 2022	SELL	$5.26 - $10.84 $176,772 - $364,299	-33,607 Reduced 10.04%	301,173 $2.11 Million
Q4 2021 Feb 11, 2022	BUY	$8.87 - $12.94 $2.32 Million - $3.39 Million	261,604 Added 357.5%	334,780 $3.41 Million
Q3 2021 Nov 12, 2021	BUY	$12.21 - $17.2 $893,478 - $1.26 Million	73,176 New	73,176 $893,000

124

65.6M

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $451M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.